Charles River Laboratories (CRL) Q3 Earnings and Revenues Beat Estimates

Charles River Laboratories (CRL) came out with quarterly earnings of $2.59 per share, beating the Zacks Consensus Estimate of$ 2.43 per share. This compares to earnings of $2.72 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 6.58%. A quarter ago, it was expected that this medical research equipment and services provider would post earnings of$ 2.39 per share when it actually produced earnings of $2.80, delivering a surprise o ...